Hi,
The work below has been done with the Gamma-OH precursor called
Butyrolactone and marketed as "Renewtrient" .
Gamma-OH will,probably,be released in the USA under the brand name of
"Xyrem".
It is also called GHB and sodium oxybate
Butyrolactone is converted,in the body,into the active Gamma-OH form
by enzymes called "lactonases".
More infos on Gamma-OH can be found at:
http://dog.net.uk/claude
Gamma-OH promises to be the equivalent of a mind penicillin,useful for
depression,panic attacks,anxiety and all psychopathologies arising
from a DEFICIT OF SOCIABILITY.
Cheers,
Cl.
RENEWTRIENT (Butyrolactone)
The natural alternative in physical and mental
health
Butyrolactone to Alleviate the Symptoms of Depression
Dr. Kenneth Cochrane
RenewTrient Products:
Abstract: Eighteen volunteers who met DSM-IV criteria for Major
Depressive Disorder were measured for degree and severity of
depression (subjective and objective). Measurement was conducted both
before and after the initial administration of RenewTrient and at
monthly intervals for a four month period.
Volunteers were maintained at a standard dosage of RenewTrient during
this period.
Concurrently, a healthy group of ten volunteers were studied under the
same conditions and administered the same measurements. Healthy
volunteers did not meet criteria for Major Depressive Disorder or any
other Psychiatric Disorder.
Results of the study indicate profound positive changes (78%)
in symptomatology and measured pathology upon initial administration
of RenewTrient and over the course of the study.
Participants reported improved mood (78%); improvement in sleep
patterns (70%); improvement in quality of sleep (76%); improvement in
sexual feelings (44%);decrease in anxiety (88%) and increased feelings
of well-being (82%).
Several additional and unexpected effects observed by the researcher
during the study were noted. These effects were not controlled for and
are therefore anecdotal: (1) subjects who were previously unable to
discuss pertinent issues (grief, loss, early trauma) were able to
readily discuss and work with these issues while being maintained on
RenewTrient; (2) subjects were more able to work with visualization,
meditation and relaxation techniques during the time they were taking
RenewTrient; (3) trance induction (for hypnotherapy) was more easily
accomplished in subjects who were originally resistant to this mode of
treatment.
Healthy volunteers differed greatly from the depressed volunteers in
both the subjective effect of RenewTrient and the experienced changes
in affect and mood.
Most healthy controls reported somnolence (92%) as the major
subjective effect of RenewTrient.
These results strongly suggest that the active components of
RenewTrient,although beneficial to the general population, are
particularly beneficial to individuals suffering from the symptoms of
depression.
Because of the small sample size and the short duration of the study,
suggestions for further research are offered.
